1. Hoffman JI. Incidence of congenital heart disease: I. postnatal incidence. Pediatr Cardiol. 1995; 16:103–113.
2. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol. 1978; 42:458–466.
3. Iga K, Hori K, Matsumura T, Gen H, Kitaguchi S, Tomonaga G, et al. A case of unusual longevity of tetralogy of Fallot confirmed by cardiac catheterization. Jpn Circ J. 1991; 55:962–965.
4. Anders HJ, Fuchshuber S. Bisoprolol treatment for cyanotic spells: a 69-year-old female with uncorrected pentalogy of Fallot. Eur J Med Res. 2001; 28:275–276.
5. Taksande A, Gautami V, Padhi S, Bakshi K. Hypercyanotic spells. J Mahatma Gandhi Inst Med Sci. 2009; 14:7–9.
6. Perloff JK. The clinical recognition of congenital heart disease. 5th ed. Philadelphia: Saunders;2003.
7. Guntheroth WG, Morgan BC, Mullins GL. Physiologic studies of paroxysmal hyperpnea in cyanotic congenital heart disease. Circulation. 1965; 31:70–76.
8. Pekdemir H, Gokhan Cin V, Necdet Akkus M, Doven O. Cyanotic tetralogy of Fallot with its infective endocarditis complication on the tricuspid and pulmonary. Circ J. 2004; 68:178–180.
9. Yasuhara J, Yamagishi H. Pulmonary arterial hypertension associated with tetralogy of Fallot. Int Heart J. 2015; 56:Suppl. S17–S21.